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ABSTRACT A new semi-rigid dipeptide mimetic was prepared in multigram scale, in good 
yield and in a stereocontrolled way, starting from commercially available and unexpensive 
reagents, i. e. N-benzyl piperidone, tosyl azide and proline methyl ester. The optimized 
multicomponent process consisted of a cascade click cycloaddition and a ring rearrangement 
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reactions, followed by a reductive step. Theoretical calculations were performed to elucidate the 
reaction mechanism and support the stereochemical outcome of the reduction. Finally, the new 
scaffold was used for the preparation of model peptidomimetics, whose β turn conformation was 
confirmed by dynamic NMR experiments. 
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Introduction 
Peptidomimetics are small synthetic molecules able to mimic peptides and protein-fragment. 
Intense research has been made on their development in the early 21st century.1 The design and 
preparation of peptidomimetics able to selectively perturb protein–protein interactions (PPI) is, in 
particular, an important challenge for both chemical biology and medicinal chemistry.2 The most 
applied approach is the use of rigid scaffolds mimicking the secondary structure of the binding 
portion involved in PPI.3 On the other hand, extreme rigidity is desirable only if the obtained 
molecular shape is exactly complementary to the binding partner, but most often PPIs rely on an 
induced fit of the two interacting units. In order to fit in the target, it is now commonly assessed 
that peptidomimetics should have several kinetically and thermodynamically accessible local 
minima representing conformations. As a result, the use of semi-rigid mimetics of secondary 
protein structures is a much more convenient approach.4  
The most prevalent non repetitive motif observed in proteins is the four residues β turn, in which 
Pro and Gly are generally found in the i+1 and i+2 positions.5 Many rigid scaffolds mimicking this 
structural motif have been developed during the years,6 and the Pro-D-Pro or D-Pro-Pro sequences 
have been demonstrated the effective semi-rigid reverse turn nucleators.7 More recently, the D-
Pro-Pro motif has also been inserted into several peptides to be used as low loading 
organocatalysts, providing higher catalytic activity and stereoselectivity than proline itself.8 
In this work, a semi-rigid dipeptide mimetic 1, containing piperidine and a NH-Tosyl 
functionalized pyrrolidine, was designed and synthesized. An efficient protocol, consisting of a 
cascade click cycloaddition and ring rearrangement reactions, followed by a reductive step, was 
developed. Our challenge was the preparation of 1 in gram scale, controlling the stereochemistry 
of the new stereocentres and without the isolation of any intermediates. (Scheme 1) Theoretical 
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calculations were performed to elucidate the reaction mechanism and supported the stereochemical 
outcome. Finally, compound 1 was used for the preparation of model peptidomimetics, whose 
conformation was studied by NMR technique. 
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Scheme 1. Retrosynthesis of reverse turn peptidomimetic 
 
RESULTS AND DISCUSSION 
Synthesis of dipeptide mimetics. Our researches have been focused on the reactions between 
sulfonylazides and enamines for a long time.9 We recently reported on a multicomponent click 
reaction between morpholine, 1-methyl-4-piperidone and tosyl azide affording azacycloalkene N-
monosulfonyl diamines, formed through a 5-amino-1,2,3-triazoline rearrangement.9a As proline is 
involved in β turn induction, we envisioned the possibility to use this amino acid as a secondary 
amine instead of morpholine, in order to obtain enantiopure compound 1 (Scheme 1). 
The robustness of the above reaction was checked using commercially available N-benzyl 
piperidone, tosyl azide and proline methyl ester hydrochloride. First, the hydrochloride salt was 
neutralized using TEA (1 eq) in 1,2 dichloroethane. N-Benzyl piperidone, molecular sieves and, 
after 1 h, tosylazide (1 eq) were added to the mixture, but the reaction did not occur. In order to 
overcome eventual issues in the formation of the enamine, a catalytic amount of InCl3 was added 
to the initial mixture of the ketone and the free amine. The sulfonylazide was then dropped and the 
reaction was complete after 45 min (TLC analysis). Any attempt to purify the crude reaction 
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mixture by crystallization failed, while it was possible to isolate only a mixture of diasteroisomeric 
amidines 2 (20%) by column chromatography. (Scheme 2)  
The compound 2 isolation was a proof that the cycloaddition/ring rearrangement reactions were 
effective. As in the recently reported mechanism for morpholino derivatives,9a proline reacts first 
with keto compound (leading to enamine A), then reacts with tosylazide, affording cycloadduct B 
in equilibrium with its conformer B’. Amidines 2 are formed through a concerted transposition of 
the piperidine ring bond and nitrogen elimination (path a). As the main products were degraded 
during the work up, our hypothesis is that, starting from conformer B, the concerted transposition 
of proline moiety and nitrogen elimination (path b) gives imine 3. The latter equilibrates to 
azacycloalkene diamine derivative 4, which was not stable during the purification on silica gel 
(Scheme 2).  
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Scheme 2. Mechanism of multicomponent reaction  
Since compounds 5 were our synthetic targets, we reasoned that the direct treatment of the 
multicomponent reaction mixture with a reducing agent, could give access to a more stable 
piperidine ring. (Scheme 2) In compounds 3/4, the reduction of the double bond of could give four 
isomers: two having a trans substitution pattern, and the others with cis disposition, respectively 
(Figure 1). Our interest was the control of the reduction stereochemical outcome, thus we tested 
different reducing agents. 
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Figure 1. Possible stereoisomers of 5 
We first performed a catalytic hydrogenation using Pd/C in MeOH (1 atm, 25 °C), which actually 
led to a complex mixture (1H NMR). Molecular weights, corresponding to amidines 2 and 
piperidines 5, together with their N-debenzylated derivatives, were detected in the mass spectrum 
of the crude. In order to avoid the formation of mixtures and the N-benzyl deprotection side 
reaction, we then turned to borohydride reducing agents.10 As reported,10b by tuning the sterical 
and electronical properties of the substituents on the boron atom, it could be possible to control 
the diastereoselection in the formation of the new stereocenters.  
A series of reducing borohydrides were tested. The reactions were directly performed on the 
crude click reaction mixture, operating at 25 °C for 10 h. Using NaBH(OAc)3 (2.5 eq), the reaction 
was successful (40% overall yield), leading exclusively to 5a and 5b isomers, together with 
amidine 2 (5a/5b/2, 2:1:1 ratio, 1H NMR and HPLC analyses, see Supporting Information). The 
same stereochemical outcome was found with NaBH3CN (2.5 eq), obtaining the only 5a and 5b 
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isomers, although their distribution was found not completely reproducible. Only degradation 
products were observed using NaBH4 (2.5 eq). The reaction did not occur with 2.5 eq of hindered 
L-selectride. A really complex reaction mixture was obtained increasing the equivalents (5 eq) of 
the reducing agent (2/5a/5b/5c,d 3:2:1:1, LC/MS analysis of the crude).  
NaBH(OAc)3 was thus selected as the best catalyst to control the diastereoselection. In order to 
enhance the yield, we increased the amount of the reducing agent (5 eq instead of 2.5 eq), obtaining 
compounds 5 in 75% yield (5a/5b, 2:1)  
Finally, the entire protocol was carried out on multigram scale (4 g of proline). The 
multicomponent reaction between the proline, N-benzyl piperidone and tosylazide was first 
performed. After removal of the solvent and molecular sieves, dichloroethane and NaBH(OAc)3 
(5 eq) were added and the mixture was left 10h at 25 °C under stirring. After column 
chromatography, compound 5a was isolated in good yield (50%), with the minor isomer 5b (25%) 
and amidine 2 (20 %). (Scheme 3)  
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Scheme 3. Scale up of multicomponent reaction 
The stereochemistry of compounds 5a and 5b was assigned by NMR analyses. The NOESY 
spectrum of 5a showed a spatial proximity between H3’ and NHTos protons, suggesting a trans 
configuration of the Pro and NHTos substituents on the piperidine ring. On the other hand, this 
spatial proximity was not found for isomer 5b. X-Ray analysis on 5a confirmed the trans 
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configuration of the substituents, indicating a R configuration of both C3’ and C4’ stereocenters, 
and the S configuration of Cα of Pro. (see Supporting Information, Figure S1) On the contrary, 
crystal structure of stereoisomer 5b showed the S and the R configuration of the C3’ and the C4’, 
respectively (see Supporting Information, Figure S6). Thus stereoisomers 5a and 5b possess the 
same stereochemistry at C4’. 
To explain the stereochemical outcome on the reduction, insights on the reaction mechanism 
were acquired.  
First of all, it can be safely assumed that between tautomers 3 and 4, the former is the most 
reactive toward hydrides, as the negative charge deriving from the nucleophilic attack at 3-C4’ can 
be delocalized on the more electronegative sulphonamide group, while on 4 it would be delocalized 
on carbon (Scheme 4). Secondly, it can be hypothesized that the hydride only attacks at the Re 
face, thus leading to the R configuration of C4’. The variability at C3’ should instead depend on 
the thermodynamic stability of the 3’R and 3’S diastereoisomeric imides 3, which are in 
equilibrium due to tautomerization between 3 and 4.  
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Scheme 4. Hypothesized mechanism for hydride attack on tautomers 3 and 4. 
Our interest focuses on theoretical analyses of chemical reactions,9a,11 and DFT calculations 
were thus done to explain the reasons for the observed stereochemistry. Indeed, a study on the 
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mechanism and diastereoselectivity of NaBH4 reduction of ketons was published by Suzuki and 
coworkers.12 They reported that DFT calculations were able to describe the geometry and energy 
of stationary point along the reaction path and correctly predict the diastereoisomeric ratio of the 
reduction of 4-methylcyclohexanone, which showed a preference for the trans isomer, and 2-
tertbutylcyclohexanone, where diastereoselectivity was almost eliminated. In these cases, 
diastereoselection was observed to be dependent from the difference in energy between the two 
transition states (TS) obtained from the axial or equatorial attack of the hydride on cyclohexanone. 
Interestingly, the authors reported that the inclusion of the Na+ counterion in the theoretical models 
was essential to reproduce the experimental results. Indeed, they demonstrated that NaBH4 is 
associated and Na+ ion takes an active part in the TS even by using methanol as the solvent. Starting 
from these findings, we thought of applying to our system the model by Suzuki et al. Some 
approximations needed to be done for reasons of feasibility. In particular, to reduce both the size 
and degrees of freedom of the system, the benzyl at N1 and the tolyl at SO2 were replaced by 
methyl groups. The effect of this simplification was evaluated by performing a conformational 
search, at the molecular mechanics (MM) level, on the approximated model of 5a (M5a) and by 
comparing the results with the X-ray structure of 5a. A root-mean-square deviation (RMSD) of 
0.52 Å was obtained between the heavy atoms of M5a most stable conformation and the 
corresponding atoms of 5a, suggesting that such approximation is not critical (Figure S9, 
Supporting Information). TS models for both the axial and equatorial hydride attack on models 
(3’R)-3 and (3’S)-3, leading to all possible diastereoisomers, were located by considering 
NaBH3CN as the reducing agent. By using NaBH(OAc)3, convergence time was unacceptably 
long. Since the two reactants substantially led to comparable stereochemical results, our 
simplification can be considered acceptable. Single point energy calculations were performed on 
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optimized geometries at the mPW1B95/6-311G(2d,p) level both in the gas phase and in 
dichloroethane.  
The obtained relative energies are summarized in Table 1, (see Supporting Information for 
absolute energies), while selected geometrical parameters are reported in Table 2. Geometries of 
all TSs deriving from either the axial or the equatorial attack of the hydride are depicted in Figure 
3. 
First of all, the most stable structures, TS-3’R,4’R-ax and TS-3’S,4’R-ax, led to the actually 
isolated compounds 5a and 5b, although gas phase calculations predict both TSs to be energetically 
equivalent. Conversely, single point energy calculations conducted in solution by using the PCM 
model provide excellent concordance with the experiments, with a ΔΔG++ = 0.5 kcal/mol in favour 
of the most abundant regioisomer 5a (5a : 5b = 2 : 1). 
 
Table 1. Relative Gibbs Free Energies (kcal/mol) Computed at the mPW1B95/6-311G(2d,p) Level 
for TSs Leading to (3’R,4’R), (3’S,4’R’), (3’R,4’S) and (3’S,4’S) Configurations of M5.a 
Model ΔΔG++gas ΔΔG++DCE 
TS-3’R,4’R-ax 0.0 0.0 
TS-3’R,4’R-eq 10.1 2.3 
TS-3’S,4’R-ax 0.0 0.5 
TS-3’S,4’R-eq 6.2 5.0 
TS-3’R,4’S-ax 1.6 2.2 
TS-3’R,4’S-eq 3.0 1.4 
TS-3’S,4’S-ax 9.2 4.9 
TS-3’S,4’S-eq 9.3 3.3 
a Gibbs Free Energies are computed by single point calculations at the mPW1B95/6-311G(2d,p) 
level on geometries optimized at the mPW1B95/6-31G(d) level in the gas phase and include 
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thermochemical corrections from vibrational analysis conducted at the same level of theory in 
standard conditions (1 atm. 298.15 K). Relative activation free energies are obtained as the 
difference between the energy computed for the considered TS and that of the most stable one. 
 
Figure 2. Geometries of all the possible TSs deriving from either the axial or equatorial attack of 
the hydride. 
Table 2. Selected Geometrical Parameters of Optimized TSs 
 
TS-3’R,4’R TS-3’S,4’R TS-3’R, 4’S TS-3’S,4’S 
 axial equat axial equat axial equat axial equat 
distances (Å) 
C4’-H 1.12 1.12 1.13 1.12 1.12 1.12 1.12 1.12 
H4’-B 2.03 2.09 2.09 1.97 2.09 2.06 2.07 2.09 
B-NSO2 2.78 3.56 3.70 2.78 3.72 3.77 2.80 3.66 
S(O2)N-Na 2.38 2.33 2.39 2.31 2.46 2.31 2.36 2.34 
OSO-Na 2.32 2.23 2.25 2.30 2.25 2.40 2.25 2.23 
C≡N-Na 2.50 2.39 2.48 2.53 2.43 2.78 2.50 2.38 
N(Pro)-Na 2.93 5.92 4.24 2.73 4.21 2.66 2.51 5.89 
C=O-Na 2.24 6.70 2.24 2.27 2.23 2.33 5.32 7.01 
 12 
angles (deg.) 
C4’-H4’-B 126.0 141.8 161.8 129.0 163.3 163.9 125.7 152.6 
C=O-Na 116.2 79.8 129.3 120.0 115.3 108.8 47.0 95.6 
C≡N-Na 96.7 112.9 119.0 95.4 119.4 106.7 95.6 116.4 
C3'-N(Pro)-Na 106.4 32.3 63.2 106.0 67.2 109.8 112.2 35.4 
C4'-N-Na 124.0 131.6 130.9 125.4 130.4 116.3 113.6 128.5 
S=O-Na 94.1 95.8 97.0 96.2 97.4 92.2 94.9 95.4 
 
The second observation deriving from theoretical results is that the axial attack of the hydride is 
the most favoured for all the examples in the gas phase, while the axial attack is still favoured in 
solution, for those paths leading to the experimentally obtained compounds 5a and 5b. Considering 
that, for the herein reported examples, NaBH(OAc)3 and NaBH3CN provided comparable results 
in terms of products stereo- and regiochemistry, so a similar mechanism of attack could be 
hypothesized. Our findings are thus apparently in contrast with the general observation that bulky 
reducing agents usually favour the equatorial attack.
10b However, our results are probably due to 
the peculiar substitution pattern of the substrate. Concerning TS-3’R,4’R, in the most favoured 
axial TS, the bulky substituents at C3’ and C4’ are both in an equatorial position (Figure 3) and no 
evident steric interferences are found by analysing the TS geometry (see Figure S10, Supporting 
Information). Moreover, the TS is stabilized by electrostatic interactions between the Na+ ion and: 
i) the partially negative charged sulphonamide nitrogen (see Scheme 4), ii) the proline nitrogen, 
iii)  the carbonyl group, iv)  the SO2 oxygen, v)  the electron rich CN group of the borohydride (see 
Table 2).  
Conversely, in the equatorial TS, the two substituents at C3’ and C4’ are both axial and only 
three stabilizing interactions are found between the Na+ ion and electron rich groups (see Figure 3 
and Table 2). Moreover, the equatorial approach of the reducing agent to the substrate is hampered 
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by steric hindrances of the methoxycarbonyl group of proline, the SO2 group and the axial 
hydrogen at C5’ (see Figure S10, Supporting Information). 
For TS-3’S,4’R, no particular differences are observed among axial and equatorial TSs on the 
steric hindrance, hampering the approach of the reducing agent to the substrate. However, in the 
equatorial TS geometry the S(O2)N···C≡N distance is 2.81 Å, while 3.31 Å is measured in the 
axial TS. This would suggest that there is on the former TS, a stronger repulsive effect between 
the electron rich sulphonamide nitrogen and the CN group. Moreover, steric interferences are also 
observed between the proline hydrogen atoms at Cα and Cδ and those at C2’, C3’ and C4’ of the 
piperidine ring, less relevant in the corresponding axial TS (Figure S11, Supporting Information). 
Concerning TS-3’R,4’S, which does not lead to experimentally isolated products, the two 
approaches, axial and equatorial, are closer in terms of relative activation energies- The former is 
favoured by 1.4 kcal/mol in the gas phase and the second is favoured by 0.8 kcal/mol in solution 
and only 1.4 kcal/mol less stable than TS-3’R,4’R. Although, the difference is little, it is enough 
to make it impossible to obtain experimentally the product, according to the Arrhenius equation13. 
Both axial and equatorial TSs pay an energy toll probably due to unfavourable steric contacts, that 
are between the methoxycarbonyl and sulphonamide methyl groups, and between the boron-linked 
hydrogen and the proline Hα (see Figure 3). 
Even for the least stable TS-3’S,4’S, the axial TS is predicted as slightly favoured in the gas 
phase, while in solution the equatorial attack is preferred, although it is still 3.3 kcal/mol less stable 
than the most favoured TS-3’R,4’R axial. Probably, the higher energy is mainly due to the 
stabilising interaction between the methoxycarbonyl group and the Na+ ion, which is missing in 
both the axial and equatorial TSs: a singularity among the cases analysed herein. 
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Taken together, the theoretical data suggest that the stereo- and regiochemical outcome observed 
experimentally can be ascribed to a fine balance of steric and electronic factors. The latter is 
dependent from the interactions between the electron-rich functional groups and the Na+ ion, 
whose role is again predicted to be extremely relevant as suggested by Suzuki et al.12 
 
Peptidomimetic synthesis. From the crystal structure of both compounds 5a and 5b (Figure S1 
and S6), it was evidenced that the carboxylic group of Pro and the benzyl substituent on the 
piperidine ring were oriented in the same direction. The spatial proximity between Cα of Pro and 
the benzyl group suggested that both scaffolds could act as a β turn nucleator when inserted into a 
peptide sequence. A preliminary conformational search conducted on the dipeptide model 7, 
deriving from the major isomer 5a,  encouraged us to pursue this idea, since a top-ranked 
conformation presented a β turn-like geometry with an H-bond between the proline amide NH and 
the acetamide carbonyl group at N1’ forming a 10-membered ring (Figure 3). Furthermore, the 
computed phy and psi values of Pro, were in the range of a type VIII β turn. 
 
Figure 3. β Turn-like geometry of dipeptide model 7 obtained by conformational search.  
In order to confirm this hypothesis, the preparation of dipeptide 7 was planned both to ascertain 
by NMR the correct orientation of the chains, and to develop the most efficient protocol for 
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peptidomimetic synthesis. Starting from 5a, the “one pot” catalytic hydrogenation/acetylation 
reaction was performed, using toluene as the solvent and adding Ac2O (2 eq) to the reaction 
mixture. Compound 6 was obtained in moderate yield (40%), then treated with MeNH2 in EtOH 
at 0°C affording 7 (50%, Scheme 5). 
To improve the yield, we tested a second synthetic protocol, consisting first of the 
functionalization of the carboxylic group and then of the deprotection of nitrogen. Compound 5a 
was thus treated with MeNH2 in EtOH at 0 °C obtaining compound 8 (96%), then deprotected with 
H2, Pd/C in toluene. The obtained free amine 9 (96%) was acetylated using Ac2O, affording 
compound 7 (64%). When the reduction was carried out in the presence of Ac2O, the yield was 
increased (95% instead of 60% in two steps). (Scheme 5) 
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Scheme 5. Synthesis of dipeptide model 7. 
We tested the possibility to use compound 5a in the synthesis of short peptide models. According 
to the above best synthetic protocol, peptidomimetic 12 was synthesized by hydrolysis of 
compound 5a (6M HCl), affording free carboxylic acid 10 (99%). Its coupling with H-Val-NH2 
using HOBT, EDC as coupling reagents, DIPEA as the base and CH2Cl2 as the solvent (10 h) 
(Scheme 6) gave compound 11 (72%). The latter was then debenzylated to derivative 12 (76%). 
Peptidomimetic 13 (45%) was finally obtained by coupling of 12 with N-Ac-Ala-OH, using the 
above condition, (Scheme 6). 
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Scheme 6 Synthesis of peptidomimetic 13. 
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NMR discussion. Compound 7 was characterized by means of 1D and 2D NMR experiments (20 
mM in CD3CN, 25 °C, 500 MHz), as well as by dynamic NMR experiments (0 to 60 °C 
temperature range in CD3CN). The 1D 
1H spectrum showed the presence of two different 
conformers 7 and 7’. (1:1 ratio, Figure 5 and Table S1 and S2, Supporting Information) Performing 
the 1H NMR analysis in DMSO, the complete coalescence of the signals was observed at 80°C. 
Dynamic NMR experiments in CD3CN showed in both isomers a high temperature coefficient for 
NHTos, while NHMe was involved in a medium-weak hydrogen bond only in 7 (see Table S2 and 
S3). In the NOESY experiments, both conformers showed spatial proximities between the Hα of 
Pro and H6’, while a NOE effect between Hα of Pro and H2’ was observed only for the hydrogen 
bonded isomer 7. On the other hand, the isomer 7’ showed a spatial proximity between Hα of Pro 
and NHMe (Figure 4) From these findings, we can postulate that the two conformers 7 and 7’ 
could correspond to the rotamers of the acetamide bond, as typically found in similar compounds.14 
We suggested that a reverse turn conformation is active for isomer 7, which is stabilized by the 
hydrogen bond. The latter consideration is also supported by the observation that compound 6, 
which possesses an acetyl group on piperidine ring and an ester function on Pro, exists as a single 
conformer in solution and shows no significative Overhauser effect in the NOESY experiments, 
lacking thus of a reverse turn conformation. 
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Figure 4. Schematic representation of conformers 7 and 7’ supported by NOE experiments.  
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Peptidomimetic 13 is present in solution as a mixture of two conformers 13/13’ (1:1 ratio, Figure 
6, Tables S3 and S4, Supporting Information). In isomer 13 NH-Val and the NH-acetyl are 
involved in medium-weak hydrogen bonds (see Tables S3 and S4), while none of the amidic 
protons of 13’ showed low temperature coefficients. In the NOESY experiments both conformers 
13 and 13’ showed spatial proximity between the Hα of Ala and H2’ and H6’. On the contrary, 
Overhauser effects between Hα of Pro and H2’ and H6’ were present only for the hydrogen bonded 
conformer 13, while spatial proximity between Hα of Pro and NH-Val was found in isomer 13’. 
These findings suggested that a β turn conformation is present in conformer 13, while 13’ 
possesses an extended conformation.  
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Figure 5 Schematic representation of conformers 13 and 13’ supported by NOE experiments. 
In conclusion, starting from commercially available cheap reagents, through a 
multicomponent/cascade process, the new scaffold 5a was prepared in multigram scale, in good 
yield and with a good control in the formation of two new stereocenters. When inserted into a 
peptide chain, compound 5a acts as a β turn nucleator, representing a promising building block 
that contains an additional amino group on the piperidine ring, which could be used for further 
functionalization of the ring. Furthermore, the semi- rigid structure of compound 5a is an added 
value for its use in the preparation of PPI modulators. 
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EXPERIMENTAL SECTION 
Materials and solvents were purchased from common commercial sources and used without 
additional purification. 1H NMR spectra were recorded at 200, 400 or 500 MHz and 13C NMR 
spectra at 50, 70 or 125 MHz using TMS as internal standard. The following abbreviations were 
used to describe peak patterns where appropriate: singlet (s), doublet (d), triplet (t), multiplet (m), 
broad resonances (br). Coupling constants (J) are reported in hertz. Mass spectra were recorded 
under electron spray interface (ESI) conditions. Infrared spectra were recorded on a FTIR 
spectrometer. [α]D Values were measured using CHCl3 as the solvent, if not differently reported. 
 
Theoretical calculations 
Transition states were fully optimized at the mPW1B95/6-31G(d) level of theory.15 Different 
conformations were evaluated for each structure and only the most stable was further considered. 
Vibrational frequencies were computed at the same level of theory in order to verify the presence 
of unique imaginary frequency corresponding to the vibrational stretching of the forming/breaking 
bonds and to calculate zero-point and thermochemical corrections to electronic energies (1 atm, 
298.15 K, unscaled frequencies). Single point calculations were then performed at the 6-
311G(2d,p) level, both in the gas phase and in solution by using the PCM solvent model for 
dichloroethane.16 All quantum chemical calculations were performed with the Gaussian09 
software package.17 Conformational searches were conducted in the gas phase by using the MOE 
software with the MMFF94x force field and default parameters. 
 
Multicomponent reaction procedure: To a suspension of proline methyl ester hydrochloride 
(4 g, 24 mmol) in 1,2 dichloroethane (40 mL), TEA (3.36 mL, 1 eq) was added. After 15 min., 
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under N2 atmosphere, 4-benzyl-piperidone (4.2 mL, 24.0 mmol) and molecular sieves (5 g) were 
added to the solution. After 30 min a catalytic amount of InCl3 (0.53 g, 0.1 eq) was added and the 
stirring was continued for 45 min. The reaction mixture was cooled at 10°C and tosylazide (4.76 
g, 24.0 mmol) dissolved dichloroethane ( 20 mL)  was added. After 45 min (TLC analysis: 
CH2Cl2/CH3OH, 20:1) (AcO)3BHNa (25.4 g, 5 eq) were added to the crude, that was left under 
stirring for 12 h at 25 °C (TLC analysis: CH2Cl2/AcOEt, 1:1). The reaction mixture was filtered, 
washed with water (3 x 30mL), dried with Na2SO4, and the solvent removed under vacuum. The 
crude was crystallized with CH3OH obtaining pure 5a (2.2 g, 20%). The mother liquor was purified 
by column chromatography (CH2Cl2/AcOEt from 100:0 to 50:50) affording a further amount of 
5a (3.2 g, 30%), together with amidine 2 (2.15 g, 20%) and 5b (2.19 g, 20%). 
S-Methyl 1-[(1-benzylpirrolidin-3-yl-(tosylimido)-methyl)]pyrrolidine-2-carboxylate (2): 
mixture of inseparable diastereoisomers, IR (KBr): 3247, 2917, 2250, 1740 cm-1; 1H NMR (CDCl3, 
200 MHz) δ 1.60-1.98 (m, 2H), 1.99-2.35 (m, 3H), 2.36-2.54 (m, 2H), 2.40 (s, 3H), 2.55-2.75 (m, 
1H), 3.00-3.20 (m, 2H), 3.45 (s, 3H), 3.55-3.95 (m, 3H), 4.05-4.35 (m, 1H), 4.36-4.55 (m, 2H), 
7.20-7.41 (m, 7H), 7.72 (d, J  7.4 Hz, 2H); 13C NMR (CDCl3, 50 MHz) δ  21.6, 25.7 (25.4), 28.6, 
29.9, 40.6, 48.9, 52.0, 54.5, 55.2, 59.9, 62.3, 126.4, 127.5 (127.7), 128.6, 128.9, 129.1 (130.1), 
138.6 (C), 141.9 (141.6) (C), 167.8 (C), 172.1 (C); MS (ESI) M+ 470; Elemental analysis (%) calcd 
for C25H31N3O4S: C 63.94, H 6.65, N 8.95. Found: C 63.72, H 6.77, N 8.72. 
 S-Methyl 1-[(3R,4R)-1-benzyl-4-tosylamido-piperidin-3-yl]pyrrolidine-2-carboxylate 
(5a): white solid, m.p. 156-157 °C (MeOH); [α]D = 108.3 (c 0.4, 20°C); IR (KBr): 3202, 2937, 
1739 cm-1; 1H NMR (CDCl3, 500 MHz) δ 1.34-1.45 (m, 1H),1.49-1.72 (m, 2H), 1.73-2.10 (m, 
5H), 2.22-2.38 (m, 2H), 2.42 (s, 3H), 2.57-2.64 (m, 1H), 2.68-2.84 (m, 3H), 3.40-3.59 (m, 3H), 
3.79 (s, 3H), 6.82 (bs, 1H), 7.15-7.31 (m, 7H), 7.80 (d, J 8.2 Hz, 2H); 13C NMR (CDCl3, 125 MHz) 
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δ 20.8, 23.7 (CH2), 29.1, 32.1, 43.5, 50.9, 51.1, 51.7,  52.9, 57.8, 61.3, 62.3, 126.5, 126.6, 127.6, 
128.2, 128.6, 136.8, 137.1, 142.1, 175.4; MS (ESI) M+ 472. Elemental analysis (%) calcd for 
C25H33N3O4S: C 63.67, H 7.05, N 8.91. Found: C 63.49, H 7.46, N 8.67. 
S-Methyl 1-[(3S,4R)-1-benzyl-4-tosylamido-piperidin-3-yl]pyrrolidine-2-carboxylate (5b): 
yellow solid, m.p. 95-97 °C (iPr2O); [α]D = (c, 20°C); IR (KBr): 3256, 2921, 1736 cm-1; NMR 
(CDCl3, 500 MHz) δ 1.37-1.42 (m, 1H), 1.67-1.72 (m, 1H), 1.79-2.10 (m, 6H), 2.43 (s, 3H), 2.59-
2.63 (m, 1H), 2.70-2.75 ( m, 1H), 2.85-2.94 (m, 3H), 2.96-3.00 (m, 1H), 3.48 (s, 2H), 3.60 (s, 3H), 
3.63 (dd, J 7.7, 3.7 Hz, 1H), 5.85 (bs, 1H), 7.20-7.35 (m, 7H), 7.78 (d, J 7.2 Hz, 2H). 13C NMR 
(CDCl3, 125 MHz) δ 21.5, 23.8, 29.6, 30.5, 49.3, 51.4, 51.5, 52.0, 54.1, 60.0, 60.3, 62.8, 127.2, 
127.3, 128.3, 129.0, 129.4, 137.7, 138.4, 143.1, 175.6; MS (ESI) M+ 472; Elemental analysis (%) 
calcd for C25H33N3O4S: C 63.67, H 7.05, N 8.91. Found: C 63.40, H 7.30, N 8.61. 
S-Methyl 1-[(3R,4R)-1-acetyl-4-tosylamido-piperidin-3-yl]pyrrolidine-2-carboxylate (6): 
To a solution of 5a (0.2 g, 0.4 mmol) and acetic anhydride (0.052 g, 0.44mmol)  in toluene (20 
mL), Pd/C (10%, 0.1 g) was added and the obtained suspension was stirred under H2 at room 
temperature for 12h. The mixture was filtered through a celite pad and the solvent was removed 
under vacuum affording pure compound 6 (0.07 g, 40%) as a colorless gum. IR (KBr): 320., 1740 
cm-1; 1H NMR (CDCl3, 300 MHz) δ 1.30-1.62 (m, 3H, 1.66-1.85 (m, 2H), 1.99-2.11 (m, 1H), 2.05 
(s, 3H), 2.32-2.60 (m, 4H), 2.44 (s, 3H), 2.82-3.10 (m, 2H), 3.77 (s, 3H), 3.40-3.78 (m, 2H), 4.55 
(d, J 9.6 Hz, 1H), 7.00 (bs, 1H, exch), 7.30 (d, J 9.9 Hz, 2H), 7.79 (d, J 6.4 Hz, 2H); 13C NMR 
(CDCl3, 50 MHz) δ  21.7, 21.9, 24.9, 30.7, 34.2, 40.5, 44.3, 45.2, 52.8, 54.1, 58.4, 62.4, 127.6, 
129.4, 137.6, 137.7, 143.4, 169.5, 176.6; MS (ESI) M+ 423; Elemental analysis (%) calcd for 
C20H29N3O5S: C 56.72, H 6.90, N 9.92. Found: C 56.55, H 7.10, N 9.73. 
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 S-N-Methyl 1-[(3R,4R)-1-acetyl-4-tosylamido)piperidin-3-yl]- pyrrolidine-2-carboxamide 
(7): Method A) Operating at 0°C and under N2 atmosphere, pure isomer 6 (0.34g, 0.85 mmol) was 
dissolved in CHCl3 (2 mL), then methylamine (8M in EtOH, 15 mL) was added. After 1h the 
mixture was warmed at room temperature and the stirring was continued overnight. The solvent 
was evaporated and pure compound 7 was obtained after crystallization from hexane (0.17 g, 
50%). Method B) To a solution of 8 (0.36 g, 0.75 mmol) in toluene (20 mL), acetic anhydride 
(0.153 g, 1.5mmol)  and Pd/C (10%, 0.08g) were added. The suspension was stirred under H2 
atmosphere at room temperature for 12h. The reaction mixture was filtered through a celite pad 
and the solvent was removed under vacuum. Pure compound 7 (0.33 g, 95%) was obtained as a 
white powder after crystallization from hexane. Method C) Pure compound 9 (58 mg, 0.15 mmol) 
was dissolved in CH2Cl2 (10 mL) and Ac2O (51 mg, 1 mmol) was added. The solution was left 
under stirring at room temperature for 5 h. The solvent was removed affording and pure 7 was 
obtained after crystallization from hexane (40 mg, 64%). IR (KBr): 3425, 3271,1659 cm-1; [α]D = 
-62.1 (c 0.3, 20°C); m. p. 60-62 °C (hexane); 1H NMR (CD3CN, 300 MHz) 1:1 mixture of 
conformers, δ 1.21-1.80 (m, 4H), 1.99-2.55 (m, 6H), 2.00 (s, 3H), 2.44 (s, 3H), 2.73, 2.75 (2 s, 
3H), 2.81-3.30 (m, 2H), 3.33-3.46 (m, 1H), 3.65-3.87 (m, 1H), 4.43-4.53 (m, 1H), 6.99, 7.11 (2 
bs, 1H, exch), 7.15 (bs, 1H, exch.), 7.39 (d, J 8.0 Hz, 2H), 7.79 (d, J 8.2 Hz, 2H);  13C NMR 
(CD3CN, 75 MHz) 1:1 mixture of conformers δ 20.9, 24.5 (24.6), 25.6, 30.8 (30.9), 33.9, 40.0, 
44.3 (44.4), 44.9, 53.9 (54.0),  58.8, 59.6, 64.0, 127.0, 129.9, 138.5, 143.7, 168.9, 175.9; MS (ESI) 
M+ 423; Elemental analysis (%) calcd for C20H30N4O4S: C 56.85, H 7.16, N 13.26. Found: C 56.68, 
H 7.30, N 13.01. 
 S-N-Methyl1-[(3R,4R)-1-Benzyl-4-tosylamido-piperidin-3-yl]-pyrrolidine-2-carboxamide 
(8): Pure isomer 5a (0.4 g, 0.85 mmol) was dissolved in CHCl3 (2 mL). Methylamine (8M in 
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EtOH, 15 mL) was added at 0°C and under N2 atmosphere. After 1h the ice bath was removed and 
the stirring continued overnight. The solvent was evaporated yielding to pure compound 8 (0.38g, 
98%) as a yellow powder after crystallization from Et2O. IR (KBr): 3307, 3087, 1655 cm
-1; [α]D = 
-75.0 (c 0.4, 20°C); m.p. 80-82°C (Et2O); 
1H NMR (CDCl3, 200 MHz) δ 1.37-2.25 (m, 7H), 2.40 
(s, 3H), 2.42-2.95 (m, 5H), 2.8 (d, J  5.14 Hz, 3H), 3.00-3.22 (m, 1H), 3.41 (d, J 11.0 Hz, 1H), 
3.47 (d, J 11.0 Hz, 1H), 5.28 (bs, 1H), 7.18-7.38 (m, 7H), 7.62 (bs, 1H, exch), 7.77 (d, J 8.1 Hz, 
2H); 13C NMR (CDCl3, 50 MHz) δ  21.7, 25.1, 26.1, 31.4, 32.5, 45.4, 51.9, 52.1, 54.2, 60.5, 62.9, 
64.4, 127.1, 127.5, 128.5, 129.1, 129.8, 137.7, 138.7, 143.4, 176.2 MS (ESI) M+ 471; Elemental 
analysis (%) calcd for C25H32N4O4S: C 61.96, H 6.66, N 11.56. Found: C 61.81, H 6.89, N 11.32. 
S-N-Methyl-1-[(3R,4R)-4-tosylamido)piperidin-3-yl]pyrrolidine-2-carboxamide (9): To a 
solution of 8 (0.29 g, 0.63 mmol) in toluene (20 mL), Pd/C (10%, 0.13 g) was added and the 
suspension was stirred for 12h under H2 at room temperature. The crude was filtered through a 
celite pad and the solvent was removed under vacuum obtaining pure compound 9 (0.2g, 96%) 
after crystallization from toluene. IR (KBr): 3436, 3271, 3176, 1658 cm-1; [α]D = -55.6 (c 0.6, 
20°C); m.p. 195-197 °C (toluene); 1H NMR (CDCl3, 300 MHz) δ 1.25-1.45 (m, 1H), 1.55-1.73 
(m, 2H), 1.75-1.91 (m, 2H), 1.95-2.13 (m, 1H), 2.22 (bs, 2H), 2.31-2.50 (m, 2H), 2.44 (s, 3H), 
2.51-2.71 (m, 2H), 2.74-2.86 (m, 1H), 2.73 (d, J 4.9 Hz, 3H), 2.86-2.97 (m, 1H), 3.0-3.12 (m, 1H), 
3.20 (dt, , J  9.1, 4.7 Hz, 1H), 3.40 (dd, J  9.6, 4.0 Hz, 1H), 7.32 (d, J 8.1 Hz, 2H), 7.64 (bs, 1H, 
exch), 7.80 (d, J 8.3 Hz, 2H); 13C NMR (CDCl3, 75 MHz) δ  21.9, 25.2, 26.3, 31.6, 34.9, 44.8, 
45.5, 45.7, 54.7, 61.8, 64.8, 127.3, 130.1, 138.8, 143.8, 176.2; MS (ESI) M+ 381 Elemental analysis 
(%) calcd for C18H28N4O3S: C 56.82, H 7.42, N 14.72. Found: C 56.59, H 7.70, N 14.48. 
 S 1-[(3R,4R)-1-Benzyl-4-tosylamido-piperidin-3-yl]pyrrolidine-2-carboxylic acid HCl 
(10): In a sealed tube, pure isomer 5a (0.1 g, 0.21 mmol) was dissolved in 6N HCl (2 mL) and 
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heated at 110°C in oil bath. The solution was stirred for 4 h and then evaporated yielding pure 
compound 10 (0.95g, 99%) as a white solid. FTIR (KBr): 3435, 3270, 1631 cm-1; [α]D = -35 (c 0.6 
in MeOH, 20°C); m.p. 95-97°C (Et2O); 
1H NMR (D2O, 200 MHz) δ 1.42-1.63 (m, 2H), 1.79-2.19 
(m, 3H), 2.30 (s, 3H), 2.22-2.33 (m, 1H), 2.78-3.00 (m, 1H), 3.19-3.45 (m, 2H), 3.50-3.82 (m, 3H), 
4.19-4.25 (m, 1H), 4.26, (d, J 13.2 Hz, 1H), 4.33 (d, J 13.2 Hz, 1H), 7.25-7.50 (m, 7H), 7.70 (d, J 
8.5 Hz, 2H); 13C NMR (D2O, 50 MHz) δ 21.0, 24.0, 27.1, 28.8, 48.3, 49.7, 50.3, 50.4, 60.0, 61.4, 
67.3, 127.1, 129.8, 130.8, 131.0 , 131.6, 127.8, 135.4, 146.4, 172.1; MS (ESI) M+ 458; Elemental 
analysis (%) calcd for C24H29N3O5S: C 61.13, H 6.20, N8.91. Found: C 60.81, H 6.53, N 8.65. 
(S)-N-((S)-1-Amino-3-methyl-1-oxobutan-2-yl)-1-((3R,4R)-1-benzyl-4-tosylamido-
piperidin-3-yl)pyrrolidine-2-carboxamide (11): To a solution of 10 (99 mg, 0.22 mmol) in 
CH2Cl2 (15 mL) and DMF (2 mL) HOBT (35 mg, 0. 26 mmol) and EDC (49 mg, 0.26 mmol) were  
added. The solution was stirred for 1h at 0°C. (S)-valinamide (36 mg, 0.24 mmol) and DIPEA 
(0.15 g, 87 mmol) were added. The mixture was stirred over night at room temperature, washed 
with water (10 mL) and with a saturated solution of NaHCO3 (10 mL). The organic layer was dried 
with Na2SO4, and evaporated under vacuum to yield 11 (0.89g, 73%) as a yellow powder. FTIR 
(KBr): 3435, 2962, 1661 cm-1; [α]D = -53 (c 0.3, 20°C); m.p. 70-73°C (Et2O); 1H NMR (CD3CN, 
300 MHz) δ 0.94 (d, J  6.7 Hz, 3H), 0.97 (d, J  6.7 Hz, 3H), 1.40-1.85 (m, 5H), 1.86-2.25 (m, 3H), 
2.42 (s, 3H), 2.40-2.60 (m, 2H), 2.68-2.75 (m, 1H), 2.85-3.10 (m, 1H), 3.20-3.35 (m, 2H), 3.38-
3.75 (m, 2H), 4.22-4.29 (m, 1H), 6.17 (bs, 1H), 6.68 (bs, 1H), 7.25-7-55 (m, 8H), 7.77 (d, J 8.2 
Hz, 2H), 7.88 (bs, 1H); 13C NMR (CD3CN, 75 MHz) δ 18.0, 19.4, 20.9, 24.7, 30.7, 31.3, 33.5, 
44.8, 51.0, 51.9, 54.2, 57.6, 58.7, 62.2, 63.6, 127.0, 127.7, 128.7, 129.5, 130.0, 138.2, 140.1, 143.6, 
174.9, 175.5; MS (ESI) M+ 556; Elemental analysis (%) calcd for C29H41N5O4S: C 62.68, H 7.44, 
N 12.60. Found: C 62.92, H 7.21, N 12.43. 
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(S)-N-((S)-1-Amino-3-methyl-1-oxobutan-2-yl)-((3R,4R)-4-tosylamido-piperidin-3-
yl)pyrrolidine-2-carboxamide (12): To a solution of 11 (50 mg, 0.09 mmol) in toluene (5 mL) 
Pd/C (10%, 0.05g) was added. The suspension was stirred under H2 atmosphere at room 
temperature for 30 h. The catalyst was filtered through a celite pad that was carefully washed with 
methanol (20 mL). The solvent was evaporated under vacuum yielding pure compound 12 (0.032g, 
76%) as a light yellow powder after crystallization from hexane. IR (KBr): 3435, 2963, 1662 cm-
1; [α]D = -24.3 (c 0.2 , 20°C); m. p. 57-59 (hexane); 1H NMR (CD3CN, 200 MHz) δ 0.94 (d, J  6.7 
Hz, 3H), 0.97 (d, J  6.7 Hz, 3H), 1.19-1.35 (m, 1H), 1.40-1.85 (m, 6H), 1.86-2.19 (m, 3H), 2.25-
2.60 (m, 4H), 2.42 (s, 3H), 2.65-2.85 (m, 1H), 2.90-3.10 (m, 1H), 3.33 (dd, J 9.9, 4.8 Hz, 1H), 4.27 
(dd, J 9.9, 6.7 Hz, 1H), 6.17 (bs, 1H), 6.68 (bs, 1H), 7.25-7.55 (m, 3H), 7.77 (d, J 8.4 Hz, 2H), 
7.90 (d, J 10.2 Hz, 1H); 13C NMR (CD3CN, 50 MHz) δ 17.8, 19.2, 20.7, 23.5, 24.6, 30.6, 31.2, 
43.7, 44.6, 45.3, 54.7, 57.3, 60.0, 63.5, 126.8, 128.5, 140.2, 143.4, 175.0, 175.4; MS (ESI) M+ 466; 
Elemental analysis (%) calcd for C22H35N5O4S: C 56.75, H 7.58, N 15.04. Found: C 56.50, H 7.90, 
N 14.85. 
(S)-1-((3R,4R)-1-((S)-2-Acetamidopropanoyl)-4-(tosylamido-piperidino-3-yl)-N-((S)-1-
amino-3-methyl-1-oxobutan-2-yl)pyrrolidine-2-carboxamide (13): To a cooled solution of N-
acetyl-(S)-alanine (16 mg, 0.121mmol) in  CH2Cl2 (5 mL), HOBT (16 mg, 0.121 mmol) and EDC 
(23 mg, 0.121mmol) were added. The mixture was stirred for 1h and 12 (47 mg, 0.101 mmol) was 
added. The solution was stirred over night at room temperature and then washed with water (10 
mL), with a saturated solution of NaHCO3 (10 mL), then dried over Na2SO4. The solvent was 
evaporated under vacuum affording 13 (26 mg, 45%) as a white powder. [α]D = +34.5 (c 0.5, 20°C); 
m.p. 62-64°C (Et2O); 
1H NMR 1:1 mixture of conformers (CD3CN, 300 MHz) δ  0.83 (d, J  6.7 
Hz, 3H), 0.97 (d, J  6.7 Hz, 3H),1.15-1.19 (m, 3 H),1.49-1.55 (m, 1H), 1.66-1.70 (m, 2H), 1.91 (s, 
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3H) 2.04-2.13 (m, 2H), 2.19-2.35 (m, 3H), 2.38 (s, 3H), 2.41-2.54 (m, 3H) , 2.91-3.01 and 2.97-
3.12 (two m, 1H), 3.18-3.23 and 3.23-3.38 (two m, 1H), 3.43-3.68 (m, 1H), 3.74-3.85 and 3.86-
3.98 (two m, 1H), 4.24-4.36 (m, 1H), 4.31-4.38 and 4.45-4.56 (two m, 1H), 4.66-4.76 (m, 1H), 
6.11 (bs, 1H, exch), 6.60 (bs, 1H, exch), 6.75 (d, J 7.2 Hz, 1H, exch), 7.28 (bs, 1H, exch), 7.38 (d, 
J 8.0 Hz,  2H), 7.76 and 7.87 (two bs, 1H, exch), 7.78 (d, J 6.6 Hz, 2H). 13C NMR (CD3CN, 75 
MHz) δ 17.9, 18.3, 19.3, 20.9, 22.3, 24.7 (24.8), 30.7 (30.9), 31.5 (31.4), 34.5 (33.5), 39.7 (41.1), 
43.4 (44.1), 44.7 (44.6), 45.1 (45.2), 54.4 (54.2), 57.6 (57.4), 58.7 (59.2), 63.5 (63.4), 127.1, 130.0, 
139.8, 143.7, 169.5 (169.2), 171.0, 174.8, 175.2; MS (ESI) M+ 577.5; Elemental analysis (%) calcd 
for C27H42N6O6S: C 56.04, H 7.31, N14.52. Found: C 55.81, H 7.60, N14.32. 
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